Author Correction: Molecular engineering of safe and efficacious oral basal insulin
Nat Commun
.
2020 Aug 20;11(1):4232.
doi: 10.1038/s41467-020-18106-3.
Authors
Frantisek Hubálek
1
,
Hanne H F Refsgaard
1
,
Sanne Gram-Nielsen
1
,
Peter Madsen
1
,
Erica Nishimura
1
,
Martin Münzel
1
,
Christian Lehn Brand
1
,
Carsten Enggaard Stidsen
1
,
Christian Hove Claussen
1
,
Erik Max Wulff
1
,
Lone Pridal
1
,
Ulla Ribel
1
,
Jonas Kildegaard
1
,
Trine Porsgaard
1
,
Eva Johansson
1
,
Dorte Bjerre Steensgaard
1
,
Lars Hovgaard
1
,
Tine Glendorf
1
,
Bo Falck Hansen
1
,
Maja Kirkegaard Jensen
1
,
Peter Kresten Nielsen
1
,
Svend Ludvigsen
1
,
Susanne Rugh
1
,
Patrick W Garibay
1
,
Mary Courtney Moore
2
,
Alan D Cherrington
2
,
Thomas Kjeldsen
3
Affiliations
1
Novo Nordisk A/S, Novo Nordisk Park 1, 2760, Maaloev, Denmark.
2
Vanderbilt University, Nashville, TN, USA.
3
Novo Nordisk A/S, Novo Nordisk Park 1, 2760, Maaloev, Denmark. ThK@novonordisk.com.
PMID:
34244486
PMCID:
PMC7441397
DOI:
10.1038/s41467-020-18106-3
No abstract available
Publication types
Published Erratum